Acarbose Tablets 25 Mg

Acarbose Tablets 25 Mg

Acarbose Tablets 25 Mg is an oral anti-diabetic medication used to manage blood sugar levels in patients with type 2 diabetes mellitus. It belongs to the class of alpha-glucosidase inhibitors, which help control post-meal blood glucose spikes. This low-dose formulation is often used as a starting dose to improve tolerance and minimize gastrointestinal side effects. It is usually prescribed along with diet and lifestyle modifications for better glycemic control. In diabetes management, higher strengths like Acarbose Tablets 50 Mg may be used, while combination therapies such as Diabetes – Janumet Tablets 50/500 Mg are prescribed for enhanced blood sugar control.

Mechanism of Action

Carbohydrate Absorption Delay

Acarbose works by inhibiting alpha-glucosidase enzymes in the intestine, slowing down the breakdown of complex carbohydrates into glucose.

Blood Sugar Control

This results in a gradual rise in blood sugar levels after meals, preventing sudden spikes. For clinical insights, refer to American Diabetes Association (ADA) and for safety guidance, consult Mayo Clinic – Acarbose Information.

Medical Uses

Acarbose Tablets 25 Mg is used for:

• Type 2 diabetes mellitus
• Postprandial (after-meal) blood sugar control
• Combination therapy with other antidiabetic drugs

It is commonly used as part of a comprehensive diabetes management plan.

Dosage and Administration

Acarbose Tablets 25 Mg is usually taken with the first bite of each main meal, as directed by a healthcare provider. The dosage may be gradually increased based on patient response. In clinical practice, Acarbose Tablets 50 Mg may be prescribed for stronger effect, while Diabetes – Janumet Tablets 50/500 Mg is used in combination therapy for better glycemic control.

Clinical Effectiveness

Clinical studies show that acarbose effectively reduces post-meal blood sugar spikes and improves overall glycemic control when used consistently.

Safety and Side Effects

Common Side Effects

• Flatulence
• Abdominal discomfort
• Diarrhea

Serious Risks

• Liver enzyme elevation (rare)
• Severe gastrointestinal issues

Monitoring is recommended during long-term use. For more details, refer to Mayo Clinic – Acarbose Information.

Contraindications and Precautions

Acarbose Tablets 25 Mg should not be used in:

• Patients with inflammatory bowel disease
• Severe kidney or liver disease
• Intestinal obstruction

Consult a healthcare provider before use.

Drug Interactions

Acarbose may interact with other antidiabetic medications, potentially increasing the risk of hypoglycemia. Patients should inform their healthcare provider about all medications they are taking. For further reading, refer to American Diabetes Association (ADA).

FAQs